# A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

> **NCT07201129** · PHASE3 · RECRUITING · sponsor: **Viatris Innovation GmbH** · enrollment: 300 (estimated)

## Conditions studied

- Nephritis, Lupus
- Lupus Erythematosus, Systemic

## Interventions

- **DRUG:** Cenerimod
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07201129
- **Lead sponsor:** Viatris Innovation GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-09
- **Primary completion:** 2029-08
- **Final completion:** 2030-02
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07201129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07201129, "A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07201129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*